Etid klinik pou Atak kè nan Maryland
3 etid pou Atak kè ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- University of Maryland, Baltimore
- Sinai Ct for Throm Res and Drug Dev, Baltimore
- Johns Hopkins Univ School of Med, Baltimore
- ak 3 plis
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins Hospital, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- ak 5 plis
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 27, 2026 · NCT06927739Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.